1. Sullivan EV, Zahr NM, Zhao Q, Pohl KM, et al.
   Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people living with HIV.
   AIDS 2024.
   


2. Schnure MC, Kasaie P, Dowdy DW, Genberg BL, et al.
   Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya.
   AIDS 2024.
   


3. Gianella S, Anderson C, Chaillon A, Wells A, et al.
   Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
   AIDS 2024.
   


4. Wijstma ES, Jongen VW, Boyd A, van den Elshout M, et al.
   Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
   AIDS 2024.
   


5. Renrong T, Li T, Zhang MX, Song TZ, et al.
   Nonnegligible contribution of non-lymphoid tissue to viral reservoir during the short-term early cART in SIVmac239-infected Chinese rhesus macaques.
   AIDS Res Hum Retroviruses 2024.
   


6. Bertumen JB, Pascopella L, Han E, Glenn-Finer R, et al.
   Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
   Clin Infect Dis 2024.
   


7. Jao J, Bonner LB, Dobinda K, Powis KM, et al.
   Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
   Clin Infect Dis 2024.
   


8. Stoopler ET, Villa A, Bindakhil M, Diaz DLO, et al.
   Common Oral Conditions: A Review.
   JAMA 2024;331:1045-1054.
   


9. Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, et al.
   Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
   J Acquir Immune Defic Syndr 2024.
   


10. Linnemayr S, Wagner Z, Saya UY, Stecher C, et al.
    Behavioral economic incentives to support HIV care: Results from a randomized controlled trial in Uganda.
    J Acquir Immune Defic Syndr 2024.
    


11. Qian Y, Zhang P, Wang L, Suo J, et al.
    The association of intraocular efavirenz concentrations and HIV-1 viral load among persons with HIV.
    J Acquir Immune Defic Syndr 2024.
    


12. Patel D, Williams WO, Wright C, Essuon A, et al.
    CDC-Funded HIV Testing and Undiagnosed HIV Infection in Ending the HIV Epidemic in the U.S. Jurisdictions.
    J Acquir Immune Defic Syndr 2024.
    


13. Olsson O, Sokilde R, Tesfaye F, Karlson S, et al.
    Tuberculosis disease is associated with elevated plasma ribonuclease activity in antiretroviral treatment-naive people with HIV.
    J Infect Dis 2024.
    


14. Xiu F, Flores Anato JL, Cox J, Grace D, et al.
    Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montreal, Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak.
    J Infect Dis 2024;229:S293-S304.
    


15. Snyder RE, Saadeh K, Tang EC, Johnson KA, et al.
    Sexual Exposures Associated With Mpox Infection: California, November 2022 to June 2023.
    J Infect Dis 2024;229:S188-S196.
    


16. Kim M, Kim E.
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol 2024;96:e29558.
    


17. Faraone JN, Wang X, Qu P, Zheng YM, et al.
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
    J Med Virol 2024;96:e29520.
    


18. Kassam P, El-Zein M, Laurie C, Tota JE, et al.
    Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men.
    J Med Virol 2024;96:e29562.
    


19. Beyrer C, Kamarulzaman A, Isbell M, Amon J, et al.
    Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet 2024.
    


20. O'Leary K.
    Combination treatment for immune-mediated HIV remission.
    Nat Med 2024.
    


21. Greybe L, Barnabas S, Cotton M, Rose P, et al.
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J 2024.
    


22. Cohen J.
    Africa may lead rollout of long-lasting HIV drug.
    Science 2024;383:1403.
    

Display articles in

• Abstract format
• Medline format